Showing results (61-70 of 150) with videos related to
Sort By:
Pageof 15
Journal of Immunology (Baltimore, Md. : 1950)|September 1, 1997
Adsorption to aluminum hydroxide promotes the activity of IL-12 as an adjuvant for antibody as well as type 1 cytokine responses to HIV-1 gp120D Jankovic, P Caspar, M Zweig, et al.Anti-Cancer Drug Design|April 1, 1986
Design, biochemical pharmacology, electrochemistry and tumour biology of anti-tumour anthrapyrazolesH D Showalter, D W Fry, W R Leopold, et al.Plos Pathogens|July 14, 2012
Antiviral activity of a small molecule deubiquitinase inhibitor occurs via induction of the unfolded protein responseJeffrey W Perry, Mohammad Ahmed, Kyeong-Ok Chang, et al.AIDS Research and Human Retroviruses|December 1, 1988
Comparative analysis of gp41 antigens by enzyme-linked immunosorbent assays for detecting antibodies to human immunodeficiency virus type 1M Zweig, S V Bladen, G C Dubois, et al.Journal of Medicinal Chemistry|November 27, 1992
Anticancer activity in murine and human tumor cell lines of bis(platinum) complexes incorporating straight-chain aliphatic diamine linker groupsA J Kraker, J D Hoeschele, W L Elliott, et al.Journal of Medicinal Chemistry|May 9, 1997
Tyrosine kinase inhibitors. 11. Soluble analogues of pyrrolo- and pyrazoloquinazolines as epidermal growth factor receptor inhibitors: synthesis, biological evaluation, and modeling of the mode of bindingB D Palmer, S Trumpp-Kallmeyer, D W Fry, et al.Journal of Medicinal Chemistry|August 19, 1994
Synthesis, structural characterization, and antitumor properties of a novel class of large-ring platinum(II) chelate complexes incorporating the cis-1,4-diaminocyclohexane ligand in a unique locked boat conformationJ D Hoeschele, H D Showalter, A J Kraker, et al.Journal of Immunology (Baltimore, Md. : 1950)|January 15, 1989
Heteroconjugate antibodies enhance cell-mediated anti-herpes simplex virus immunityC V Paya, D J McKean, D M Segal, et al.Biochemical Pharmacology|September 7, 2000
Biochemical and cellular effects of c-Src kinase-selective pyrido[2, 3-d]pyrimidine tyrosine kinase inhibitorsA J Kraker, B G Hartl, A M Amar, et al.Oncogene|February 1, 1988
Characterization and localization of the products of the human homologs of the v-ets oncogeneS Fujiwara, R J Fisher, A Seth, et al.Pageof 15